AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
INDUCTION OF TYROSINASE-REACTIVE T-CELLS BY TREATMENT WITH DACARBAZINE, CISPLATIN, INTERFERON-ALPHA + - INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA/
Authors: SCHMITTEL A KEILHOLZ U MAX R THIEL E SCHEIBENBOGEN C
Citation: A. Schmittel et al., INDUCTION OF TYROSINASE-REACTIVE T-CELLS BY TREATMENT WITH DACARBAZINE, CISPLATIN, INTERFERON-ALPHA + - INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA/, International journal of cancer, 80(1), 1999, pp. 39-43
RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS
Authors: KEILHOLZ U CONRADT C LEGHA SS KHAYAT D SCHEIBENBOGEN C THATCHER N GOEY SH GORE M DORVAL T HANCOCK B PUNT CJA DUMMER R AVRIL MF BROCKER EB BENHAMMOUDA A EGGERMONT AMM PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP
Authors: KEILHOLZ U STOTER G PUNT CJA SCHEIBENBOGEN C LEJEUNE F EGGERMONT AMM
Citation: U. Keilholz et al., RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP, The cancer journal from Scientific American, 3, 1997, pp. 22-28
A SENSITIVE ELISPOT ASSAY FOR DETECTION OF CD8-LYMPHOCYTES SPECIFIC FOR HLA CLASS I-BINDING PEPTIDE EPITOPES DERIVED FROM INFLUENZA PROTEINS IN THE BLOOD OF HEALTHY DONORS AND MELANOMA PATIENTS( T)
Authors: SCHEIBENBOGEN C LEE KH MAYER S STEVANOVIC S MOEBIUS U HERR W RAMMENSEE HG KEILHOLZ U
Citation: C. Scheibenbogen et al., A SENSITIVE ELISPOT ASSAY FOR DETECTION OF CD8-LYMPHOCYTES SPECIFIC FOR HLA CLASS I-BINDING PEPTIDE EPITOPES DERIVED FROM INFLUENZA PROTEINS IN THE BLOOD OF HEALTHY DONORS AND MELANOMA PATIENTS( T), Clinical cancer research, 3(2), 1997, pp. 221-226
UV-INDUCED N-RAS MUTATIONS ARE T-CELL TARGETS IN HUMAN-MELANOMA
Authors: VANELSAS A SCHEIBENBOGEN C VANDERMINNE C ZERP SF KEILHOLZ U SCHRIER PI
Citation: A. Vanelsas et al., UV-INDUCED N-RAS MUTATIONS ARE T-CELL TARGETS IN HUMAN-MELANOMA, Melanoma research, 7, 1997, pp. 107-113
POLYMERASE CHAIN-REACTION DETECTION OF CIRCULATING TUMOR-CELLS
Authors: KEILHOLZ U WILLHAUCK M SCHEIBENBOGEN C DEVRIES TJ BURCHILL S
Citation: U. Keilholz et al., POLYMERASE CHAIN-REACTION DETECTION OF CIRCULATING TUMOR-CELLS, Melanoma research, 7, 1997, pp. 133-141
A RANDOMIZED TRIAL OF IFN-ALPHA IL-2 WITH OR WITHOUT CDDP IN ADVANCEDMELANOMA - AN EORTC MELANOMA COOPERATIVE GROUP TRIAL/
Authors: KEILHOLZ U GOEY SH PUNT CJA SCHEIBENBOGEN C PROEBSTLE T SALZMANN R SCHADENDORF D LIENARD D EGGERMONT AMM
Citation: U. Keilholz et al., A RANDOMIZED TRIAL OF IFN-ALPHA IL-2 WITH OR WITHOUT CDDP IN ADVANCEDMELANOMA - AN EORTC MELANOMA COOPERATIVE GROUP TRIAL/, European journal of cancer, 33, 1997, pp. 1159-1159
DETECTION OF CLONALLY REARRANGED T-CELL-RECEPTOR GAMMA-CHAIN GENES FROM T-CELL MALIGNANCIES AND ACUTE INFLAMMATORY RHEUMATIC DISEASE USING PCR AMPLIFICATION, PAGE, AND AUTOMATED-ANALYSIS
Authors: WITZENS M MOHLER T WILLHAUCK M SCHEIBENBOGEN C LEE KH KEILHOLZ U
Citation: M. Witzens et al., DETECTION OF CLONALLY REARRANGED T-CELL-RECEPTOR GAMMA-CHAIN GENES FROM T-CELL MALIGNANCIES AND ACUTE INFLAMMATORY RHEUMATIC DISEASE USING PCR AMPLIFICATION, PAGE, AND AUTOMATED-ANALYSIS, Annals of hematology, 74(3), 1997, pp. 123-130
INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP
Authors: KEILHOLZ U GOEY SH PUNT CJA PROEBSTLE TM SALZMANN R SCHEIBENBOGEN C SCHADENDORF D LIENARD D ENK A DUMMER R HANTICH B GEUEKE AM EGGERMONT AMM
Citation: U. Keilholz et al., INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP, Journal of clinical oncology, 15(7), 1997, pp. 2579-2588
DETECTION OF CLONALLY REARRANGED T-CELL RECEPTOR-GAMMA GENES FROM T-CELL MALIGNANCIES AND AUTOIMMUNE-DISEASE USING PCR AMPLIFICATION, PAGE AND AUTOMATED-ANALYSIS
Authors: WITZENS M WILLHAUCK M SCHEIBENBOGEN C RINALDI N KEILHOLZ U
Citation: M. Witzens et al., DETECTION OF CLONALLY REARRANGED T-CELL RECEPTOR-GAMMA GENES FROM T-CELL MALIGNANCIES AND AUTOIMMUNE-DISEASE USING PCR AMPLIFICATION, PAGE AND AUTOMATED-ANALYSIS, Experimental hematology, 25(8), 1997, pp. 609-609
EVALUATION OF THE INTERFERON-GAMMA ELISPOT-ASSAY FOR QUANTIFICATION OF PEPTIDE-SPECIFIC T-LYMPHOCYTES FROM PERIPHERAL-BLOOD
Authors: SCHMITTEL A KEILHOLZ U SCHEIBENBOGEN C
Citation: A. Schmittel et al., EVALUATION OF THE INTERFERON-GAMMA ELISPOT-ASSAY FOR QUANTIFICATION OF PEPTIDE-SPECIFIC T-LYMPHOCYTES FROM PERIPHERAL-BLOOD, Journal of immunological methods, 210(2), 1997, pp. 167-174
ANALYSIS OF THE T-CELL RESPONSE TO TUMOR AND VIRAL PEPTIDE ANTIGENS BY AN IFN-GAMMA-ELISPOT ASSAY
Authors: SCHEIBENBOGEN C LEE KH STEVANOVIC S WITZENS M WILLHAUCK M WALDMANN V NAEHER H RAMMENSEE HG KEILHOLZ U
Citation: C. Scheibenbogen et al., ANALYSIS OF THE T-CELL RESPONSE TO TUMOR AND VIRAL PEPTIDE ANTIGENS BY AN IFN-GAMMA-ELISPOT ASSAY, International journal of cancer, 71(6), 1997, pp. 932-936
ENDOCRINE FUNCTION AND BONE METABOLISM 5 YEARS AFTER AUTOLOGOUS BONE-MARROW BLOOD-DERIVED PROGENITOR-CELL TRANSPLANTATION
Authors: KEILHOLZ U MAX R SCHEIBENBOGEN C WUSTER C KORBLING M HAAS R
Citation: U. Keilholz et al., ENDOCRINE FUNCTION AND BONE METABOLISM 5 YEARS AFTER AUTOLOGOUS BONE-MARROW BLOOD-DERIVED PROGENITOR-CELL TRANSPLANTATION, Cancer, 79(8), 1997, pp. 1617-1622
T-CELL RECEPTOR-BETA VARIABLE REGION DIVERSITY IN MELANOMA METASTASESAFTER INTERLEUKIN 2-BASED IMMUNOTHERAPY
Authors: WILLHAUCK M MOHLER T SCHEIBENBOGEN C PAWLITA M BROSSART P SCHMIER JW KEILHOLZ U
Citation: M. Willhauck et al., T-CELL RECEPTOR-BETA VARIABLE REGION DIVERSITY IN MELANOMA METASTASESAFTER INTERLEUKIN 2-BASED IMMUNOTHERAPY, Clinical cancer research, 2(4), 1996, pp. 767-772
EXPRESSION OF GP100 IN MELANOMA METASTASES RESECTED BEFORE OR AFTER TREATMENT WITH IFN-ALPHA AND IL-2
Authors: SCHEIBENBOGEN C WEYERS I RUITER D WILLHAUCK M BITTINGER A KEILHOLZ U
Citation: C. Scheibenbogen et al., EXPRESSION OF GP100 IN MELANOMA METASTASES RESECTED BEFORE OR AFTER TREATMENT WITH IFN-ALPHA AND IL-2, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 375-380
REGULATION OF INTERLEUKIN-8 MESSENGER-RNA EXPRESSION AND PROTEIN SECRETION IN A MELANOMA CELL-LINE BY TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA
Authors: MOHLER T SCHEIBENBOGEN C HAFELE J WILLHAUCK M KEILHOLZ U
Citation: T. Mohler et al., REGULATION OF INTERLEUKIN-8 MESSENGER-RNA EXPRESSION AND PROTEIN SECRETION IN A MELANOMA CELL-LINE BY TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, Melanoma research, 6(4), 1996, pp. 307-311
A PHASE-II STUDY OF DACARBAZINE, CISPLATIN, INTERFERON-ALPHA AND HIGH-DOSE INTERLEUKIN-2 IN POOR-RISK METASTATIC MELANOMA
Authors: PROEBSTLE TM SCHEIBENBOGEN C STERRY W KEILHOLZ U
Citation: Tm. Proebstle et al., A PHASE-II STUDY OF DACARBAZINE, CISPLATIN, INTERFERON-ALPHA AND HIGH-DOSE INTERLEUKIN-2 IN POOR-RISK METASTATIC MELANOMA, European journal of cancer, 32A(9), 1996, pp. 1530-1533
A SENSITIVE PROLIFERATION ASSAY TO DETERMINE THE SPECIFIC T-CELL RESPONSE AGAINST HLA-A2.1-BINDING PEPTIDES
Authors: MAYER S SCHEIBENBOGEN C LEE KH KEILHOLZ W STEVANOVIC S RAMMENSEE HG KEILHOLZ U
Citation: S. Mayer et al., A SENSITIVE PROLIFERATION ASSAY TO DETERMINE THE SPECIFIC T-CELL RESPONSE AGAINST HLA-A2.1-BINDING PEPTIDES, Journal of immunological methods, 197(1-2), 1996, pp. 131-137
CLINICAL RELEVANCE OF CYTOKINES IL-6, IL- 8, AND C-REACTIVE PROTEIN IN THE BLOOD OF PATIENTS WITH ACUTE-PANCREATITIS
Authors: STOELBEN E NAGEL M OCKERT D QUINTEL M SCHEIBENBOGEN C KLEIN B SAEGER HD
Citation: E. Stoelben et al., CLINICAL RELEVANCE OF CYTOKINES IL-6, IL- 8, AND C-REACTIVE PROTEIN IN THE BLOOD OF PATIENTS WITH ACUTE-PANCREATITIS, Chirurg, 67(12), 1996, pp. 1231-1236
INTRAHEPATIC ADOPTIVE IMMUNOTHERAPY WITH AUTOLOGOUS TUMORCYTOTOXIC MACROPHAGES IN PATIENTS WITH CANCER
Authors: HENNEMANN B SCHEIBENBOGEN C SCHUMICHEN C ANDREESEN R
Citation: B. Hennemann et al., INTRAHEPATIC ADOPTIVE IMMUNOTHERAPY WITH AUTOLOGOUS TUMORCYTOTOXIC MACROPHAGES IN PATIENTS WITH CANCER, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 19-27
ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS
Authors: KEILHOLZ U SCHEIBENBOGEN C MOHLER T BROSSART P MACLACHLAN D GEUEKE AM JOCHIM A HUNSTEIN W
Citation: U. Keilholz et al., ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS, Melanoma research, 5(4), 1995, pp. 283-287
SERUM INTERLEUKIN-8 (IL-8) IS ELEVATED IN PATIENTS WITH METASTATIC MELANOMA AND CORRELATES WITH TUMOR LOAD
Authors: SCHEIBENBOGEN C MOHLER T HAEFELE J HUNSTEIN W KEILHOLZ U
Citation: C. Scheibenbogen et al., SERUM INTERLEUKIN-8 (IL-8) IS ELEVATED IN PATIENTS WITH METASTATIC MELANOMA AND CORRELATES WITH TUMOR LOAD, Melanoma research, 5(3), 1995, pp. 179-181
RESTRICTION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN MELANOMA METASTASIS RESPONDING TO IMMUNOTHERAPY
Authors: MOHLER T WILLHAUCK M SCHEIBENBOGEN C PAWLITA M BLUDAU H BROSSART P HUNSTEIN W KEILHOLZ U
Citation: T. Mohler et al., RESTRICTION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN MELANOMA METASTASIS RESPONDING TO IMMUNOTHERAPY, Melanoma research, 5(2), 1995, pp. 129-132
BIOLOGICAL RESPONSE TO INTRAHEPATIC ADOPTIVE IMMUNOTHERAPY WITH AUTOLOGOUS INTERFERON ACTIVATED MACROPHAGES
Authors: HENNEMANN B SCHEIBENBOGEN C ANDREESEN R
Citation: B. Hennemann et al., BIOLOGICAL RESPONSE TO INTRAHEPATIC ADOPTIVE IMMUNOTHERAPY WITH AUTOLOGOUS INTERFERON ACTIVATED MACROPHAGES, European journal of cancer, 31A(5), 1995, pp. 852-852
A PROLIFERATION ASSAY TO DETERMINE SPECIFIC T-CELL IMMUNITY USING HLAI-BINDING PEPTIDES
Authors: SCHEIBENBOGEN C MAYER S KEILHOLZ W STEVANOVIC S ANDERS M RAMMENSEE HG KEILHOLZ U
Citation: C. Scheibenbogen et al., A PROLIFERATION ASSAY TO DETERMINE SPECIFIC T-CELL IMMUNITY USING HLAI-BINDING PEPTIDES, European journal of cancer, 31A, 1995, pp. 38-38
Risultati: 1-25 | 26-39